• Client Login
Ozmosi
  • Services
    • BEAM Clinical Trial Data
    • GCT Global Clinical Trials
    • PRYZM Pharma Product Database
    • KRYSTL Industry Scan Reporting
    • LENZ Company Pipeline Summary
    • Specialized Consulting
    • Approved Pharmaceutical Products in Use
  • About Us
  • Case Studies
  • Newsroom
  • Contact Us
Select Page
China Reshaping the Clinical Trial Pipeline

China Reshaping the Clinical Trial Pipeline

Sep 19, 2022 | Clinical Trial Trends, Global Trends

Finally, the data is in here at OZMOSI, and we can start tracking and reporting on the clinical development expected to come out of China.  Gone are the days of developing drugs only in the US and then watching them slowly make their way to the rest of the world....

Keeping up with the Pharmaceutical Industry in Asia

Jun 1, 2022 | Clinical Trial Trends, Global Trends

Keeping up with the pharmaceutical landscape around the world, especially in Asia, is essential in today’s market. Here are some of the biggest news stories emerging from Asian countries that are making big strides in drug development. China: Recently, China has been...

Recent Posts

  • Healthiest States Index of The USA 2023May 8, 2023
  • FDA Accelerated Approval, Breakthrough Therapy, and Fast Track Designations Supercharge Drug DevelopmentMarch 9, 2023
  • Using Data to Optimize Clinical Trial RecruitmentJanuary 23, 2023
  • Uncovering New Catalyst Events in the Pharmaceutical and Biotech MarketsNovember 11, 2022
  • New Developments in Alzheimer’s TreatmentOctober 7, 2022
  • The Clinical Trial PowershiftSeptember 19, 2022
  • Home
  • About Us
  • Services
  • Case Studies
  • Newsroom
  • Contact Us
  • Facebook
  • Twitter
OZMOSI© 2023 | All Rights Reserved | Site by Webtyde